By the Numbers: Percent Share of Novel FDA Drug Approvals in Four Major Therapeutic Categories, 1980-2018.
Between 1980 and 2018, novel cancer drug approvals as a percentage share of all novel FDA drug approvals increased from 4.5% to 26.7%.